Norman Zinberg

Last updated
Norman Zinberg
Born1922
DiedApril 2, 1989
Occupation Psychoanalyst and psychiatrist
Known forAddiction research

Dr. Norman Earl Zinberg (born 1922, Harrisburg, Pennsylvania - d. April 2, 1989, Cambridge, Massachusetts [1] ) was a psychoanalyst and psychiatrist whose research into addiction is seen as a great influence on current clinical models and greatly influenced the work of addiction treatment specialists such as Stanton Peele. He was a clinical professor of psychiatry at the Harvard Medical School and a psychiatrist at Cambridge Hospital. He also taught at Boston University and the Tufts School of Medicine. Zinberg earned his bachelor's and doctoral degrees from the University of Maryland. [2]

Zinberg studied recreational heroin users over a ten-year period, and his book Drug, Set, and Setting: The Basis for Controlled Intoxicant Use explains with data and case histories why people's relation to drug use could change according to type of drug (including its method of ingestion), their mindset, and social setting. One of his early studies in the area concerned a number of American soldiers who became addicted to heroin during the Vietnam War as what Zinberg viewed as an attempt to "blot out" the intensity of their environment. Once back in the States, their usage "virtually ceased"; 88% of the soldiers did not become readdicted after returning stateside. [3] His work contradicted the idea that some people have "addictive personalities" while other do not.

Dr. Howard Shaffer, a colleague at Harvard and at Cambridge Hospital, said about Zinberg "He had a remarkable impact on our understanding that drug effects are not simply a consequence of biochemistry. He showed that an individual's expectations, his psychological set and his social milieu interact to produce the effects on behavior that we observe. Equally important, Norman Zinberg helped us explain why an addictive drug affects a person differently at different times and how it affects various people in different ways." [4]

In addition to his addiction work, Zinberg was one of the first appointees to the National AIDS Commission.

Norman Zinberg collaborated on some studies and books with his wife Dorothy Zinberg.

Related Research Articles

Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin or amphetamines. The general intent is to enable the patient to confront substance dependence, if present, and stop substance misuse to avoid the psychological, legal, financial, social, and physical consequences that can be caused.

Alcohol dependence is a previous psychiatric diagnosis in which an individual is physically or psychologically dependent upon alcohol.

Opioid use disorder Medical condition

Opioid use disorder (OUD) is a substance use disorder relating to the use of an opioid. Any such disorder causes significant impairment or distress. Signs of the disorder include a strong desire to use opioids, increased tolerance to opioids, difficulty fulfilling obligations, trouble reducing use, and withdrawal symptoms with discontinuation. Opioid withdrawal symptoms may include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are components of a substance use disorder. Complications may include opioid overdose, suicide, HIV/AIDS, hepatitis C, and problems at school, work, or home.

Set and setting, when referring to a psychedelic drug experience, means one's mindset and the physical and social environment in which the user has the experience. This is especially relevant for psychedelic experiences in either a therapeutic or recreational context. According to the book How to Change Your Mind by Michael Pollan, the concept of set and setting was observed by the "Johnny Appleseed" of LSD, Al Hubbard visiting mushroom ceremonies in Mexico. The terms were used at least as early as 1958 by Ludwig von Bertalanffy and popularized by Timothy Leary in 1961, and became widely accepted by researchers in psychedelic therapy. Norman Zinberg has also discussed this in Drug, Set, And Setting: The Basis for Controlled Intoxicant Use (1984).

Substance dependence, also known as drug dependence, is an adaptive state that develops from repeated drug administration, and which results in withdrawal upon cessation of drug use. A drug addiction, a distinct concept from substance dependence, is defined as compulsive, out-of-control drug use, despite negative consequences. An addictive drug is a drug which is both rewarding and reinforcing. ΔFosB, a gene transcription factor, is now known to be a critical component and common factor in the development of virtually all forms of behavioral and drug addictions, but not dependence.

Sexual addiction, also known as sex addiction, is a state characterized by compulsive participation or engagement in sexual activity, particularly sexual intercourse, despite negative consequences.

Abdol Hamid Ghodse was an academic in the field of substance abuse and addiction.

Ibogaine Psychoactive substance found in plants in the family Apocynaceae

Ibogaine is a naturally occurring psychoactive substance found in plants in the family Apocynaceae such as Tabernanthe iboga, Voacanga africana, and Tabernaemontana undulata. It is a psychedelic with dissociative properties.

Addiction medicine is a medical subspecialty that deals with the diagnosis, prevention, evaluation, treatment, and recovery of persons with addiction, of those with substance-related and addictive disorders, and of people who show unhealthy use of substances including alcohol, nicotine, prescription medicine and other illicit and licit drugs. The medical subspecialty often crosses over into other areas, since various aspects of addiction fall within the fields of public health, psychology, social work, mental health counseling, psychiatry, and internal medicine, among others. Incorporated within the specialty are the processes of detoxification, rehabilitation, harm reduction, abstinence-based treatment, individual and group therapies, oversight of halfway houses, treatment of withdrawal-related symptoms, acute intervention, and long term therapies designed to reduce likelihood of relapse. Some specialists, primarily those who also have expertise in family medicine or internal medicine, also provide treatment for disease states commonly associated with substance use, such as hepatitis and HIV infection.

Most countries have legislation designed to criminalise some drug use. Usually however the legislative process is self-referential, defining abuse in terms of what is made illegal. The legislation concerns lists of drugs specified by the legislation. These drugs are often called illegal drugs but, generally, what is illegal is their unlicensed production, supply and possession. The drugs are also called controlled drugs or controlled substances.

David C. Lewis was Professor Emeritus of Medicine and Community Health and the Donald G. Millar Distinguished Professor of Alcohol and Addiction Studies at Brown University.

Maressa Orzack American psychologist

Dr. Maressa Hecht Orzack was an American psychologist who was Clinical Associate in Psychology at McLean Hospital; Coordinator of Behavior Therapy Affective Disease Program, also at McLean Hospital and Assistant Clinical Professor of Psychology, Department of Psychiatry at Harvard Medical School. She also held private practice at Newton Centre.

Herbert David Kleber was an American psychiatrist and substance abuse researcher. His career, centered on the evidence-based treatment of addiction, focused on scientific approaches in place of punishment and moralisms. His career focused on pathology of addiction to help patients reduce the severe discomforts of withdrawal, avoid relapse and stay in recovery.

Marie Nyswander was an American psychiatrist and psychoanalyst known for developing and popularizing the use of methadone to treat heroin addiction.

Substance use disorder Continual use of drugs (including alcohol) despite detrimental consequences

Substance use disorder (SUD) is the persistent use of drugs despite substantial harm and adverse consequences. Substance use disorders are characterized by an array of mental/emotional, physical, and behavioral problems such as chronic guilt; an inability to reduce or stop consuming the substance(s) despite repeated attempts; driving while intoxicated; and physiological withdrawal symptoms. Drug classes that are involved in SUD include: alcohol; cannabis; phencyclidine and other hallucinogens, such as arylcyclohexylamines; inhalants; opioids; sedatives, hypnotics, or anxiolytics; stimulants; tobacco; and other or unknown substances.

Addiction A disease resulting in compulsive engagement in rewarding stimuli despite adverse consequences

Addiction is a biopsychosocial disorder characterized by repeated use of drugs, or repetitive engagement in a behavior such as gambling, despite harm to self and others. According to the "brain disease model of addiction," while a number of psychosocial factors contribute to the development and maintenance of addiction, a biological process that is induced by repeated exposure to an addictive stimulus is the core pathology that drives the development and maintenance of an addiction. Many scholars who study addiction argue that the brain disease model is incomplete and misleading.

Addiction psychiatry is a medical subspecialty within psychiatry that focuses on the evaluation, diagnosis, and treatment of people who are suffering from one or more disorders related to addiction. This may include disorders involving legal and illegal drugs, gambling, sex, food, and other impulse control disorders. Addiction psychiatrists are substance use disorder experts. Growing amounts of scientific knowledge, such as the health effects and treatments for substance use disorders, have led to advancements in the field of addiction psychiatry. These advancements in understanding the neurobiology of rewarding behavior, along with federal funding, has allowed for ample opportunity for research in the discipline of addiction psychiatry. Addiction psychiatry is an expanding field, and currently there is a high demand for substance use disorder experts in both the private and public sector.

Psychoactive drug Chemical substance that alters nervous system function

A psychoactive drug, psychopharmaceutical, or psychotropic drug is a chemical substance that changes nervous system function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.

Professionals view addiction as a disease or a choice. One model is referred to as the Disease model of addiction. The second model is the Choice model of addiction. Researchers argue that the addiction process is like the disease model with a target organ being the brain, some type of defect, and symptoms of the disease. Addiction is like the choice model with a disorder of genes, a reward, memory, stress, and choice. Both models result in compulsive behavior.

Edward Khantzian is a professor of psychiatry at Harvard Medical School. Beginning in the 1970s, he developed a progressively more coherent and empirically-grounded self-medication hypothesis of drug abuse, which states that individuals use drugs in an attempt to self-medicate states of distress and suffering.

References

  1. Norman E. Zinberg, 67, Pioneer In Treatments for Abuse of Drugs The New York Times April 4, 1989.
  2. Norman E. Zinberg, 67, Pioneer In Treatments for Abuse of Drugs The New York Times April 4, 1989.
  3. Zinberg, Norman (1986). Drug, Set, And Setting: The Basis For Controlled Intoxicant Use. Yale University Press. pp. x–xi. ISBN   0-300-03634-5.
  4. Fowler, Glenn (1989-04-04). "Norman E. Zinberg, 67, Pioneer In Treatments for Abuse of Drugs". New York Times . pp. D-27. Retrieved 2009-03-15.CS1 maint: discouraged parameter (link)